Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
boric acid solution
- Development stage
- Unknown
- Lead developer
- VULM
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Boric acid solution is a topical antiseptic and disinfectant formulation containing 3% boric acid. Developed and marketed by VULM, it is used for gentle surface disinfection of the skin and possesses mild anti-inflammatory properties. Boric acid exerts its antiseptic effect by slightly slowing the multiplication of bacteria and fungi. It is characterized by good local tolerance but carries a risk of systemic absorption toxicity if applied to large areas of broken skin.
- Other names
- Boric acid solution 3%Solutio acidi boriciSolutio acidi borici 3%bórová vodabórová voda 3%
Beyond the preview
Go deeper on boric acid solution.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on boric acid solution.